Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Other hematologic neoplasm 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Breast Neoplasms 3865Motor Activity 228Neoplasms 202Prostatic Neoplasms 167Colorectal Neoplasms 146Lung Neoplasms 139Lymphedema 125Fatigue 104Ovarian Neoplasms 98Carcinoma, Intraductal, Noninfiltrating 94Colonic Neoplasms 86Breast Cancer Lymphedema 86Pain 81Breast Cancer Female 76Anxiety Disorders 76Uterine Cervical Neoplasms 73Depression 70Triple Negative Breast Neoplasms 66Breast Carcinoma In Situ 66Head and Neck Neoplasms 55Pain, Postoperative 54Obesity 54Neoplasm Metastasis 48Melanoma 42Endometrial Neoplasms 39Pancreatic Neoplasms 38Lymphoma 38Carcinoma, Non-Small-Cell Lung 34Sleep Initiation and Maintenance Disorders 33Sarcoma 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Behavioral Symptoms × Breast × Clear all
NCT04379414 2025-12-09

YES

Dana-Farber Cancer Institute

Phase NA Active not recruiting
400 enrolled
Breast

Behavioral Symptoms, Breast Neoplasms

NCT02043184 2017-06-07

Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR

Michigan State University

Phase NA Completed
322 enrolled
BreastDermatologicGastrointestinalGenitourinaryOther hematologic neoplasm

Behavioral Symptoms, Breast Neoplasms, Depression, Leukemia, Melanoma, Neoplasms, Patient Acceptance of Health Care, Prostatic Neoplasms, Colorectal Neoplasms, Neurobehavioral Manifestations, Medication Adherence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡